ESHG 2021 Conference – Satellite symposium replay
With @Eurofins Biomnis, SeqOne recently held a symposium on CNV detection in exome data, performance comparisons with traditional method and the clinical impact of fast reliable exome CNV detection.
SHORTCUT TO THE TALKS OF THE SESSION:
1:27 Prof. Laurent Mesnard, PhD in Physiopathology, MD Nephrologist, Hospital Tenon/Sorbonne University exploring the clinical impact of fast reliable exome CNV results in adult nephrology,
15:36 Laure Raymond, Geneticist, Eurofins / Biomnis, discussing challenges involved in interpreting exome CNV and performance compared to traditional approaches,
29:48 Samantha Brunel, PhD in Molecular Biology, SeqOne Genomics product expert presenting implementation exome CNV analysis in clinical routine.
39:57 Q&A session
Would you like to test our exome CNV solution or know more about it?
Contact us today at sales@seqone.com
Similar readings
-
Events News22 September 2023
Genomic data interpretation workshop & lunch seminar in Graz
We will be hosting a workshop & lunch seminar about genomic data interpretation. DATE: November 8th 2023 starting at 10:00, with lunch at 12:00 LOCATION: [...]
-
Events News
11 May 2023
SeqOne at ESHG 2023: A.I. for Diagnostics
We will be hosting a corporate satellite on Monday, June 12, 2023 – 14.00 – 15.30 BST : "Harnessing AI to improve diagnostic yield with [...]
-
News Press release
22 February 2023
SeqOne’s new clinically validated HRD test reduces the number of inconclusive results to improve the prescription of targeted treatments for ovarian cancer patients
The Homologous Recombination Deficiency (HRD) biomarker identifies ovarian cancer patients likely to respond to PARP inhibitors. SeqOne’s test simplifies the deployment of this test while [...]
